Atul Tandon’s Post

AstraZeneca India continues to advance its mission of transforming the future of healthcare by unlocking the power of science. The company's commitment to innovation is reflected in its strong pipeline progress, reinforcing its position as a key player in the healthcare industry.   Recently, AstraZeneca unveiled its new Bold Ambition during the Global Investor’s Day setting the stage for 2030! Aspiring to be pioneers in science, focused on transform patient outcomes, by 2030, globally we will deliver 20 new medicines, industry leading growth and aim to be carbon negative.   In India, we have recently announced our financial results for FY 2023-24 with 29% growth in revenue, which is one of our strongest years of performance. We owe this our talented, committed and passionate group of employees who go above and beyond in terms of achieving greater milestones every single day to transform the lives of patients. Proud to be part of a company that is unlocking the power of what science can do for people, society and the planet.   Read more here: https://lnkd.in/gtJHuUeK   #ScienceCan #AZProud

We are excited to announce that AstraZeneca is a Silver Partner for the International eHealth Forum – Morocco 2024! The commitment is to enhance access to innovative medicines and improve patient care at this year’s event, scheduled for October 30-31, 2024, in Casablanca. As a global pharmaceutical company centered on patients, AstraZeneca strives to unlock the power of science. The teams work tirelessly to push the boundaries of science to deliver life-changing medications. By 2030, AstraZeneca aims to launch at least 15 new medicines and achieve carbon negativity, making a meaningful impact on patients, society, and the planet. Heartfelt gratitude goes to all partners for their dedication to excellence in healthcare. Together, this event will serve as a significant milestone for the future of health technologies in Morocco! Fondation Mohammed VI des Sciences et de la Santé CIES, e-Health Innovation Center International eHealth Forum – Morocco #AstraZeneca #SilverPartner #InternationalEHealthForum #Morocco2024 #HealthcareInnovation #PatientCare #Pharmaceuticals #LifeChangingMedications #Science #SustainableHealthcare #HealthTech #GlobalHealth #AccessToMedicines #FutureOfHealthcare #CarbonNegativity #HealthcareExcellence

Healthcare is entering a defining moment, with an opportunity to embrace a new wave of innovation. Yet if Europe is to realise the full potential of these breakthroughs, it is vital that people across the region have more timely and equitable access to these treatments.   It is with this potential in mind that I take up a new position on the Board of the European Federation of Pharmaceutical Industries and Associations (EFPIA) – the main body representing the research-based biopharmaceutical industry in Europe.   Alongside my peers from world-leading pharmaceutical companies, I will be working to help deliver on EFPIA’s mission to create an environment that enables our industry to innovate, thrive and deliver new therapies across Europe. At Pfizer, our goal is to change the lives of one billion patients a year by 2027 – but as EFPIA’s mission alludes, this is only possible with the right policy and legislative environment in place.   Europe is often seen as a pharmaceutical powerhouse, with the skilled workforce, academic infrastructure, multi-national institutions, and manufacturing capability making it a location of choice for life science investment. Yet in spite of all this expertise and promise there is still significant inequity in access to new medicines. Patients in Europe are having to wait 517 days for access to innovative treatments on average, ranging from 128 days up to a staggering 1,351 days.* This is an unacceptable situation, and I believe our industry is and should remain an important voice in profiling and remedying this issue. Timely and equitable access is a cause I am deeply passionate about. Through my new role on the EFPIA Board, I am committed to finding and fighting for solutions in partnership with policymakers and stakeholders across Europe, based on a shared understanding of the root causes of unavailability and access delays. This is a real opportunity to create a modernised system that can embrace the next generation of medicines and vaccines. Together, I hope we can achieve a healthier and stronger Europe. * https://lnkd.in/egnbJgvd   #EFPIA #HealthPolicy #LifeSciences #HealthofEurope #MedicineAccess  

Collaboration for a Healthier Future! AstraZeneca Pharma India Ltd and Mankind Pharma join forces to enhance access to vital asthma medication in India. Together, INDIA is making strides in healthcare. Stay tuned for more updates and photos from this exciting venture on our LinkedIn page! #pharmacollaboration #healthcareinnovation

Centered around the theme Viksit Bharat @2047 — India's Path from the 'Pharmacy of the World' to the 'Pharma Powerhouse to the World', the summit set forth the vision for India's healthcare evolution. Organisation of Pharmaceutical Producers of India #healthcare #PharmaIndustrialIndia

Collaboration for a Healthier Future! AstraZeneca Pharma India Ltd and Mankind Pharma join forces to enhance access to vital asthma medication in India. Together, INDIA is making strides in healthcare. Stay tuned for more updates and photos from this exciting venture on our LinkedIn page! #pharmacollaboration #healthcareinnovation 

🌍 Shaping the Future of Indian Pharma At the OPPI India Annual Summit 2024, industry leaders gathered to discuss transformative strategies for establishing India as a global pharmaceutical powerhouse. 💊 With insights on innovation, sustainability, and collaboration, the event underscored India's potential to lead in delivering affordable, high-quality healthcare solutions to the world. 📖 Dive deeper into the key takeaways and industry vision here: #PharmaLeadership #HealthcareInnovation #IndiaPharma #OPPI2024

Since the National Pharmaceutical Congress wrapped up its 18th session one week ago today, you may have noticed that the event has received 30,000 exposures and engagements on LinkedIn and social media. I believe this is what you call "blowing up." That's some impressive amplification metric for a conference that drew around 250 delegates, faculty and sponsors to the Mississauga Convention Centre. You might ask, "What's the secret recipe?" Ain't no secret. Come gather round, and I'll tell you. 1. Meaningful content: NPC does not provide podium time for supplier pitches. Other events might follow a "pay for play" model. We don't. We provide a platform for the brightest minds in the life sciences. That's it. 2. Say it quickly: Our speakers have learned a couple of things from TED Talks. They each have a point -- and they don't take an hour to get to it when seven minutes will suffice. NPC is one very full day. Because, really, who has time to hang around a longer conference? 3. Canadian Healthcare Marketing Hall of Fame: Since 2001, more than 150 individuals who have made a significant and lasting impact on the life sciences have been honoured by their peers through this meaningful recognition. Of course, there are other industry awards programs. This is one that counts for something. 4. Established value: NPC is supported consistently by the Finest Companies in the Life Sciences. You know the names. They are:  -- 3H Communications -- Bayshore HealthCare -- BioScript Solutions -- Blue Charm Adherence -- Cencora -- Canadian Pharmaceutical Distribution Network -- Chronicle Companies -- Council for Continuing Pharmaceutical Education   -- EMREACH Inc. -- Gibson Group Inc. -- Impres -- Inizio Engage -- IQVIA -- McKesson Canada -- Peak Pharma Solutions -- Shoppers Drug Mart Specialty Health Network -- The Pangaea Group -- Toc Toc Communications 5. Other ingredients, in the form of commitment, passion, and purpose. An accommodating and inclusive atmosphere. A culture of curiosity. And the desire to give something back. Since the first NPC, we have raised more than $70,000 for Canadian health-related charities through Sandi's Fund. 6. One other essential element, in the irreplaceable form of Mr. Joseph Knott. There you have the entire playbook for the coming 2025 National Pharmaceutical Congress, which will be the 19th iteration. No doubt some may try to copy the formula. Whatever. If you'd like to join the NPC family in the coming year, just get in touch through a DM, or leave a message below. Door's open. #NPC2025 #nationalpharmaceuticalcongress #healthforeveryone https://lnkd.in/e4PtpqQ